Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
4493 | 1702 | 45.2 | 90% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
202 | 20434 | CLOPIDOGREL//PRASUGREL//ASPIRIN RESISTANCE |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | GLYCOPROTEIN VI | Author keyword | 126 | 77% | 5% | 85 |
2 | GPVI | Author keyword | 69 | 70% | 3% | 57 |
3 | CLEC 2 | Author keyword | 33 | 77% | 1% | 23 |
4 | E348 | Address | 24 | 91% | 1% | 10 |
5 | AUSTRALIAN BLOOD DIS | Address | 18 | 24% | 4% | 67 |
6 | CONVULXIN | Author keyword | 15 | 67% | 1% | 14 |
7 | GPIB IX V | Author keyword | 13 | 67% | 1% | 12 |
8 | RHODOCYTIN | Author keyword | 11 | 100% | 0% | 6 |
9 | SOL SHERRY THROMBOSIS | Address | 10 | 16% | 4% | 60 |
10 | COLLAGEN RELATED PEPTIDE | Author keyword | 9 | 83% | 0% | 5 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | GLYCOPROTEIN VI | 126 | 77% | 5% | 85 | Search GLYCOPROTEIN+VI | Search GLYCOPROTEIN+VI |
2 | GPVI | 69 | 70% | 3% | 57 | Search GPVI | Search GPVI |
3 | CLEC 2 | 33 | 77% | 1% | 23 | Search CLEC+2 | Search CLEC+2 |
4 | CONVULXIN | 15 | 67% | 1% | 14 | Search CONVULXIN | Search CONVULXIN |
5 | GPIB IX V | 13 | 67% | 1% | 12 | Search GPIB+IX+V | Search GPIB+IX+V |
6 | RHODOCYTIN | 11 | 100% | 0% | 6 | Search RHODOCYTIN | Search RHODOCYTIN |
7 | COLLAGEN RELATED PEPTIDE | 9 | 83% | 0% | 5 | Search COLLAGEN+RELATED+PEPTIDE | Search COLLAGEN+RELATED+PEPTIDE |
8 | ALPHA2BETA1 | 7 | 53% | 1% | 9 | Search ALPHA2BETA1 | Search ALPHA2BETA1 |
9 | GLYCOPROTEIN VI GPVI | 6 | 80% | 0% | 4 | Search GLYCOPROTEIN+VI+GPVI | Search GLYCOPROTEIN+VI+GPVI |
10 | PLATELET COLLAGEN RECEPTOR | 6 | 80% | 0% | 4 | Search PLATELET+COLLAGEN+RECEPTOR | Search PLATELET+COLLAGEN+RECEPTOR |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | GLYCOPROTEIN VI | 161 | 51% | 13% | 229 |
2 | INTEGRIN ALPHA2BETA1 | 104 | 73% | 5% | 79 |
3 | GPVI | 73 | 71% | 4% | 60 |
4 | GAMMA CHAIN COMPLEX | 61 | 95% | 1% | 20 |
5 | COLLAGEN RECEPTOR | 57 | 36% | 8% | 130 |
6 | RECEPTOR GLYCOPROTEIN VI | 54 | 64% | 3% | 54 |
7 | PHOSPHOLIPASE C GAMMA 2 | 53 | 37% | 7% | 117 |
8 | INTEGRIN ALPHAIIBBETA3 | 49 | 33% | 7% | 122 |
9 | THROMBUS FORMATION | 46 | 18% | 14% | 238 |
10 | ANTITHROMBOTIC PROTECTION | 37 | 100% | 1% | 14 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Platelet-collagen interaction: is GPVI the central receptor? | 2003 | 486 | 137 | 76% |
Targeting platelet receptors in thrombotic and thrombo-inflammatory disorders | 2015 | 1 | 113 | 73% |
Cell adhesion mechanisms in platelets | 2008 | 200 | 113 | 48% |
Platelet adhesion and activation mechanisms in arterial thrombosis and ischaemic stroke | 2011 | 56 | 166 | 54% |
Primary haemostasis: newer insights | 2014 | 10 | 82 | 45% |
Platelet Immunoreceptor Tyrosine- Based Activation Motif ( ITAM) Signaling and Vascular Integrity | 2014 | 8 | 132 | 53% |
The future of glycoprotein VI as an antithrombotic target | 2012 | 14 | 94 | 94% |
Platelet GPVI: a target for antithrombotic therapy?! | 2012 | 14 | 71 | 80% |
Arterial thrombosis-insidious, unpredictable and deadly | 2011 | 108 | 148 | 24% |
GPVI and CLEC-2 in hemostasis and vascular integrity | 2010 | 50 | 96 | 64% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | E348 | 24 | 91% | 0.6% | 10 |
2 | AUSTRALIAN BLOOD DIS | 18 | 24% | 3.9% | 67 |
3 | SOL SHERRY THROMBOSIS | 10 | 16% | 3.5% | 60 |
4 | CHAIR VASC MED | 5 | 45% | 0.5% | 9 |
5 | CHAIR EXPT BIOMED | 4 | 75% | 0.2% | 3 |
6 | PHYSIOL MED ENDOCRINE | 4 | 75% | 0.2% | 3 |
7 | UMR S1148 | 4 | 75% | 0.2% | 3 |
8 | RUDOLF VIRCHOW | 4 | 11% | 2.1% | 36 |
9 | EXPT HEMOSTASIS THROMBOSIS | 4 | 23% | 0.8% | 14 |
10 | DFG EXPT BIOMED | 3 | 13% | 1.5% | 25 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000228122 | C TYPE LECTIN LIKE PROTEIN//ANTICOAGULATION FACTOR I//ANTICOAGULATION FACTOR II |
2 | 0.0000203693 | PLATELET APOPTOSIS//COATED PLATELET//STUDY HUMAN OPERATOR PERFORMANCE |
3 | 0.0000134366 | BERNARD SOULIER SYNDROME//MAY HEGGLIN ANOMALY//EPSTEIN SYNDROME |
4 | 0.0000131291 | PLATELET PROTEOME//EFS AUVERGNE LOIRE//SECT CARDIOIMMUNOL |
5 | 0.0000103054 | GLANZMANN THROMBASTHENIA//GLANZMANNS THROMBASTHENIA//THROMBASTHENIA |
6 | 0.0000094206 | DERMCIDIN ISOFORM 2//ACUTE ISCHEMIC HEART DISEASE//GEA 3175 |
7 | 0.0000084495 | HUMAN PLATELET//PLATELETS HUMAN//ATPASE CA2 MG2 |
8 | 0.0000083240 | PRIMA CLIN MED//BIOMED EVOLUT AGING//CLIN LIPID |
9 | 0.0000081109 | UTP//P2Y RECEPTORS//MOL RECOGNIT SECT |
10 | 0.0000077219 | VON WILLEBRAND DISEASE//VON WILLEBRAND FACTOR//VWD |